Lili Ma
No.1838, Guangzhou North Road
Guangzhou, 510515, China
Guangzhou, 510515, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Acetylated KLF5 inhibits LACTB transcription, mediates mitochondrial dynamics, and regulates colorectal cancer cell stemness and differentiation.
Journal: International journal of biological macromolecules
Published: May 26, 2025
Diagnostic challenges of rarely well-differentiated adenocarcinoma of the stomach.
Journal: Pathology oncology research : POR
Published: April 26, 2025
LACTB promotes cell differentiation and inhibits cell proliferation in colorectal cancer.
Journal: Biochimica et biophysica acta. General subjects
Published: December 18, 2024
PCBP1 protects bladder cancer cells from mitochondria injury and ferroptosis by inducing LACTB mRNA degradation.
Journal: Molecular carcinogenesis
Published: December 28, 2022
Is antitumor Pt(IV) complex containing two axial lonidamine ligands a true dual- or multi-action prodrug?
Journal: Metallomics : integrated biometal science
Published: April 25, 2022
MIF/SCL3A2 depletion inhibits the proliferation and metastasis of colorectal cancer cells via the AKT/GSK-3β pathway and cell iron death.
Journal: Journal of cellular and molecular medicine
Published: April 14, 2021
ERp29 counteracts the suppression of malignancy mediated by endoplasmic reticulum stress and promotes the metastasis of colorectal cancer.
Journal: Oncology reports
Published: July 29, 2018
Monochalcoplatin: An Actively Transported, Quickly Reducible, and Highly Potent PtIV Anticancer Prodrug.
Journal: Angewandte Chemie (International ed. in English)
Published: April 12, 2018
A Cancer Cell-Selective and Low-Toxic Bifunctional Heterodinuclear Pt(IV)-Ru(II) Anticancer Prodrug.
A Cancer Cell-Selective and Low-Toxic Bifunctional Heterodinuclear Pt(IV)-Ru(II) Anticancer Prodrug.
Journal: Inorganic chemistry
Published: February 14, 2018
Telepathology consultation for frozen section diagnosis in China.
Journal: Diagnostic pathology
Published: December 16, 2017
Heterodinuclear Pt(iv)-Ru(ii) anticancer prodrugs to combat both drug resistance and tumor metastasis.
Journal: Chemical communications (Cambridge, England)
Published: August 11, 2016
Efficient co-delivery of a Pt(IV) prodrug and a p53 activator to enhance the anticancer activity of cisplatin.
Journal: Chemical communications (Cambridge, England)
Published: April 10, 2015
Last Updated: 09/26/2026